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We examined the impact factor 
for all English-language journals as a 
proxy for quality of science. We could 
not evaluate the Russian-language 
journals by impact factor because 
they are not included in the Journal 
Citation Report. The median impact 
factor of articles with a central Asian 
author (groups B and C) was 2·53.
Of 85 interviewees, 61 were from 
Kazakhstan. Most interviewees 
(67 [79%]) were physicians and a 
small number (12 [14%]) characterised 
themselves as making health-care 
decisions other than at a patient 
level. Only 15 (18%) participants 
rated their English as proﬁ cient. 
Although 74 of 84 (88%) interviewees 
thought evidence-based medicine is 
important, most respondents (40/66 
[61%]) thought that it is not used 
in health-care decision-making, and 
only 27/59 (46%) thought English-
language sources were used in health-
care decision-making. When asked 
about evidence-based medicine 
teaching in medical schools or post-
graduate education, 34/59 (58%) 
and 24/54 (44%) of respondents, 
respectively, thought that evidence-
based medicine is not provided or 
rarely used in the educational process. 
Employees of western agencies in 
central Asia such as UN agencies (n=7) 
were less likely to think evidence-
based medicine was used in medical 
education or that English-language 
sources were used in health-care 
decision-making than were the local 
health-care professionals. 
The results of our study indicate 
that countries of central Asia still have 
barriers to integration into world 
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Evidence-based health systems 
are extremely important for the 
improvement of global health.1 In 
1991, the ﬁ ve republics of central 
Asia (population 61 million), 
geopolitically strategically located 
and rich in natural resources, gained 
independence from the Soviet Union 
but inherited the Soviet health-care 
system. The Cold War limited exposure 
to international medical science, and 
reliance on Russian-oriented scientiﬁ c 
thinking, with near-exclusive use 
of the Russian language in national 
science, created barriers to the use of 
and contribution to English-based 
sources of medical science. 20 years 
after independence, our experience is 
that these barriers persist. To assess 
the current contribution of central 
Asian scientists to medical science, 
we analysed the quantity and scope 
of medical literature from central Asia 
published between January, 2009, and 
July, 2011. To ascertain perceptions of 
the use of evidence-based medicine 
in central Asia, we also did semi-
structured interviews with 85 medical 
scientists, medical educators, and 
health-care professionals from central 
Asia (appendix).
We identiﬁ ed 345 publications 
regarding data from central Asia and 
separated papers into three groups. 
Group A contained papers with 
only foreign authors—we used this 
category to examine publications 
with no inﬂ uence by central Asian 
scientists (n=104). The remaining 
papers with participation of local 
authors were separated into two 
groups on the basis of the aﬃ  liation 
of the ﬁ rst author. Group B contained 
papers with the ﬁ rst author from 
central Asia (n=167), and group C 
contained papers with the ﬁ rst author 
from outside central Asia (n=74). 
We reasoned that projects published 
with the ﬁ rst author from central Asia 
were probably led by central Asian 
scientists, whereas the ﬁ rst author 
from outside central Asia indicated 
leadership by foreign scientists.
Nearly half of all publications (48%, 
n=167) had the ﬁ rst author from 
central Asia (5·6 publications per 
month). Of ﬁ rst-authored papers, 
Uzbekistan had the highest number 
of publications and the highest 
percentage of publications in English 
(table).
The most frequently used languages 
were English (260 papers) and Russian 
(82 papers). Papers including foreign 
authors (groups A and C) were mostly 
written in English (98/104 [94%] and 
68/74 [92%], respectively), and only 
95/167 (57%) of papers with the ﬁ rst 
author from central Asia (group B) 
were in English.
With our analysis restricted to 
papers with participation of a 
central Asian author (groups B 
and C), the two journals that authors 
published in most frequently were in 
Russian—Meditsinskaia parazitologiia i 
parazitarnye bolezni (Med Parazitol) and 
Gigiena i Sanitariya (Gig Sanit). BioMed 
Central was the most common 
English-language journal. Few journals 
that central Asian scientists publish 
in are readily accessed by Western 
scientists. No journals originating in 
central Asia are indexed in PubMed.
We categorised the main subject area 
for each paper on the basis of keywords 
or, if keywords were not available, by 
reviewing the abstract and making 
our best judgment. The subjects most 
often addressed were: epidemiology 
(n=110), public health (n=96), 
environmental sciences (n=28), 
chemistry (n=25), general medicine 
(n=23), genetics (n=22), pharmacology 
(n=15), and physics (n=9). The 
emphasis on health sciences was less 
prominent in group B publications, 
with pharmacology, chemistry, and 
physics far more common than 
in groups A and C. We believe this 
diﬀ erence is consistent with the known 
strength of Russian basic sciences.
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Number of 
publications
Russian-
language
English-
language
Annualised 
publication number
Uzbekistan 73 23 (32%) 50 (68%) 29·2
Kazakhstan 53 25 (47%) 28 (53%) 21·2
Kyrgyzstan 24 12 (50%) 12 (50%) 9·6
Tajikistan 17 12 (71%) 5 (29%) 6·8
Turkmenistan 0 0 0 0
Table: Publications by country of origin of ﬁ rst author in countries of central 
Asia, between January, 2009, and July, 2011
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scientiﬁ c processes. The disparity of 
scientiﬁ c publications between the 
developing and industrialised worlds 
has been noted.2 In 2003, former 
UN Secretary-General Koﬁ  Annan 
noted that developing nations had 
a population-adjusted proportion 
of scientists 10–30 times smaller 
than did developed nations and 
called for reduction of the resultant 
research gap that threatened national 
development.3 The small contribution 
of central Asian health scientists 
to world scientiﬁ c literature and 
practice, and, conversely, the low use 
of knowledge from these sources, 
impedes health-care developments 
in the region and the ability to assess 
changes in public health of former 
Soviet countries.4
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